BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22383950)

  • 1. Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection.
    Boyapalle S; Wong T; Garay J; Teng M; San Juan-Vergara H; Mohapatra S; Mohapatra S
    PLoS One; 2012; 7(2):e29386. PubMed ID: 22383950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.
    Ban J; Lee NR; Lee NJ; Lee JK; Quan FS; Inn KS
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30558248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.
    Foronjy RF; Dabo AJ; Cummins N; Geraghty P
    BMC Immunol; 2014 Oct; 15():41. PubMed ID: 25277705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.
    Webster Marketon JI; Corry J; Teng MN
    Virology; 2014 Jan; 449():62-9. PubMed ID: 24418538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.
    Van Royen T; Sedeyn K; Moschonas GD; Toussaint W; Vuylsteke M; Van Haver D; Impens F; Eyckerman S; Lemmens I; Tavernier J; Schepens B; Saelens X
    J Virol; 2022 Oct; 96(19):e0129722. PubMed ID: 36102648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I.
    Ling Z; Tran KC; Teng MN
    J Virol; 2009 Apr; 83(8):3734-42. PubMed ID: 19193793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between NS1 and Cellular MAVS Contributes to NS1 Mitochondria Targeting.
    Tseng YY; Kuan CY; Mibayashi M; Chen CJ; Palese P; Albrecht RA; Hsu WL
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses.
    Sedeyn K; Schepens B; Saelens X
    PLoS Pathog; 2019 Oct; 15(10):e1007984. PubMed ID: 31622448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
    He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
    J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Chaperone Protein 14-3-3ε in the Regulation of Influenza A Virus-Activated Beta Interferon.
    Tam EH; Liu YC; Woung CH; Liu HM; Wu GH; Wu CC; Kuo RL
    J Virol; 2021 Sep; 95(20):e0023121. PubMed ID: 34379499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Influenza A Virus RNA Products Mediate MAVS-Dependent Upregulation of Human Leukocyte Antigen Class I Proteins.
    Rahim MMA; Parsons BD; Price EL; Slaine PD; Chilvers BL; Seaton GS; Wight A; Medina-Luna D; Dey S; Grandy SL; Anderson LE; Zamorano Cuervo N; Grandvaux N; Gaglia MM; Kelvin AA; Khaperskyy DA; McCormick C; Makrigiannis AP
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5.
    Zhang HL; Ye HQ; Liu SQ; Deng CL; Li XD; Shi PY; Zhang B
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons.
    Makris S; Bajorek M; Culley FJ; Goritzka M; Johansson C
    J Innate Immun; 2016; 8(5):452-63. PubMed ID: 27423203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF- kappa B-inducing kinase signaling pathway.
    Liu P; Li K; Garofalo RP; Brasier AR
    J Biol Chem; 2008 Aug; 283(34):23169-78. PubMed ID: 18550535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus.
    Mibayashi M; Martínez-Sobrido L; Loo YM; Cárdenas WB; Gale M; García-Sastre A
    J Virol; 2007 Jan; 81(2):514-24. PubMed ID: 17079289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors.
    Foronjy RF; Taggart CC; Dabo AJ; Weldon S; Cummins N; Geraghty P
    Mucosal Immunol; 2015 Jan; 8(1):161-75. PubMed ID: 25005357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness.
    Lo MS; Brazas RM; Holtzman MJ
    J Virol; 2005 Jul; 79(14):9315-9. PubMed ID: 15994826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus NS1 protein degrades STAT2 by inducing SOCS1 expression.
    Xu X; Zheng J; Zheng K; Hou Y; Zhao F; Zhao D
    Intervirology; 2014; 57(2):65-73. PubMed ID: 24480984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.
    Lifland AW; Jung J; Alonas E; Zurla C; Crowe JE; Santangelo PJ
    J Virol; 2012 Aug; 86(15):8245-58. PubMed ID: 22623778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.